Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Harman

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Medical Care|February 4, 2010
Association of Health Plans' Healthcare Effectiveness Data and Information Set (HEDIS) performance with outcomes of enrollees with diabetesJeffrey S Harman, Sarah Hudson Scholle, Judy H Ng, et al.
Annals of Internal Medicine|June 13, 1998
Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trialJ H Essell, M T Schroeder, G S Harman, et al.
The Journal of Biological Chemistry|March 23, 2004
Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesisDae J Kim, Taro E Akiyama, Fred S Harman, et al.
Seminars in Oncology|August 1, 1993
Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2)E A Copelan, J C Biggs, J Szer, et al.
Cancer Research|September 15, 1988
Phase I clinical trial of carbetimerA R Hanauske, T J Melink, G S Harman, et al.
European Journal of Applied Physiology|April 11, 2025
Incremental ascent to 4300 m does not alter standing balance in lowlanders or Tibetan highlandersJessica A Dickenson, Taylor S Harman, Ajaya J Kunwar, et al.
Journal of Neurophysiology|May 19, 2026
High-altitude hypoxia alters the visual control of standing balance in lowlanders and Tibetan highlandersJessica A Dickenson, Taylor S Harman, Ajaya J Kunwar, et al.
Cancer Research|August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleG S Harman, J B Craig, J G Kuhn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2006
A "weight-listing" paradox for candidates of renal transplantation?J D Schold, T R Srinivas, G Guerra, et al.
Selective Cancer Therapeutics|January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleP W Cobb, K A Havlin, J G Kuhn, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Medical Care|February 4, 2010
Association of Health Plans' Healthcare Effectiveness Data and Information Set (HEDIS) performance with outcomes of enrollees with diabetesJeffrey S Harman, Sarah Hudson Scholle, Judy H Ng, et al.
Annals of Internal Medicine|June 13, 1998
Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trialJ H Essell, M T Schroeder, G S Harman, et al.
The Journal of Biological Chemistry|March 23, 2004
Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesisDae J Kim, Taro E Akiyama, Fred S Harman, et al.
Seminars in Oncology|August 1, 1993
Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2)E A Copelan, J C Biggs, J Szer, et al.
Cancer Research|September 15, 1988
Phase I clinical trial of carbetimerA R Hanauske, T J Melink, G S Harman, et al.
European Journal of Applied Physiology|April 11, 2025
Incremental ascent to 4300 m does not alter standing balance in lowlanders or Tibetan highlandersJessica A Dickenson, Taylor S Harman, Ajaya J Kunwar, et al.
Journal of Neurophysiology|May 19, 2026
High-altitude hypoxia alters the visual control of standing balance in lowlanders and Tibetan highlandersJessica A Dickenson, Taylor S Harman, Ajaya J Kunwar, et al.
Cancer Research|August 15, 1988
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose scheduleG S Harman, J B Craig, J G Kuhn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2006
A "weight-listing" paradox for candidates of renal transplantation?J D Schold, T R Srinivas, G Guerra, et al.
Selective Cancer Therapeutics|January 1, 1991
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion scheduleP W Cobb, K A Havlin, J G Kuhn, et al.
Pageof 13